Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices

被引:51
|
作者
Ray, Kimberly M. [1 ]
Kerlikowske, Karla [2 ]
Lobach, Iryna V. [2 ]
Hofmann, Michael B. [2 ]
Greenwood, Heather I. [1 ]
Arasu, Vignesh A. [1 ]
Hylton, Nola M. [1 ]
Joe, Bonnie N. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 1600 Divisadero St,Room C250, San Francisco, CA 94115 USA
[2] Univ Calif San Francisco, Dept Med & Epidemiol, 1600 Divisadero St,Room C250, San Francisco, CA 94115 USA
关键词
CONTRAST-MEDIUM ENHANCEMENT; FIBROGLANDULAR TISSUE; FOLLOW-UP; IMPACT; THERAPY; WOMEN; LINE;
D O I
10.1148/radiol.2017170811
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the effect of background parenchymal enhancement (BPE) on breast magnetic resonance (MR)imaging interpretive performance in a large multi-institutional cohort with independent analysis of screening and diagnostic MR studies. Materials and Methods: Analysis of 3770 breast MR studies was conducted. Examinations were performed in 2958 women at six participating facilities in the San Francisco Bay Area from January 2010 to October 2012. Findings were recorded prospectively in the San Francisco Mammography Registry. Performance measures were compared between studies with low BPE (mild or minimal) and those with high BPE (moderate or marked) by using binomial tests of proportions. Results: Of 1726 MR imaging studies in the screening group, 1301 were classified as having low BPE and 425 were classified as having high BPE (75% vs 25%, respectively; P <.001). Of 2044 MR imaging studies in the diagnostic group, 1443 were classified as having low BPE and 601 were classified as having high BPE (71% vs 29%, respectively; P <.001). For low versus high BPE groups at screening, abnormal interpretation rate was 157 of 1301 versus 111 of 424 (12% vs 26%, P <.001); biopsy recommendation rate was 85 of 1301 versus 54 of 424 (7% vs 13%, P <.001); and specificity was 89% (95% confidence interval [CI]: 87, 91) versus 75% (95% CI: 71, 80) (P=.01). For the low versus high BPE groups at diagnostic MR imaging, biopsy recommendation rate was 325 of 1443 versus 195 of 601 (23% vs 32%, P <.001); and specificity was 86% (95% CI: 84, 88) versus 75% (95% CI: 74, 82) (P <.001). There were no significant differences between studies with low versus high BPE in sensitivity for screening (76% [95% CI: 55, 91] vs 83% [95% CI: 52, 98]; P=.94) or diagnostic (93% [95% CI: 87, 97] vs 96% [95% CI: 87, 99]; P=.69) MR imaging, nor were there significant differences in cancer detection rate per 1000 patients between the low BPE versus high BPE groups for screening (15 per 1000 vs 24 per 1000, P=.30) or diagnostic (78 per 1000 vs 85 per 1000, P=.64) MR imaging. Conclusion: Relative to MR studies with minimal or mild BPE, those with moderate or marked BPE were associated with higher abnormal interpretation and biopsy rates and lower specificity, with no difference in cancer detection rate. (C) RSNA, 2017
引用
收藏
页码:822 / 829
页数:8
相关论文
共 50 条
  • [31] Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging
    Yoon, Hai-Jeon
    Kim, Yemi
    Lee, Jee Eun
    Kim, Bom Sahn
    EUROPEAN RADIOLOGY, 2015, 25 (01) : 32 - 40
  • [32] Impact of Background Parenchymal Enhancement in Preoperative Magnetic Resonance Imaging Breast Assessment for Women with Newly Diagnosed Breast Cancer
    Wan, W. S.
    Lee, C. Y.
    Lui, C. Y.
    HONG KONG JOURNAL OF RADIOLOGY, 2015, 18 (02): : 141 - 145
  • [33] Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging
    Hai-Jeon Yoon
    Yemi Kim
    Jee Eun Lee
    Bom Sahn Kim
    European Radiology, 2015, 25 : 32 - 40
  • [34] Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging
    Kawamura, Akiko
    Satake, Hiroko
    Ishigaki, Satoko
    Ikeda, Mitsuru
    Kimura, Reiko
    Shimamoto, Kazuhiro
    Naganawa, Shinji
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2015, 77 (03): : 425 - 437
  • [35] Three-Dimensional Quantitative Validation of Breast Magnetic Resonance Imaging Background Parenchymal Enhancement Assessments
    Ha, Richard
    Mema, Eralda
    Guo, Xiaotao
    Mango, Victoria
    Desperito, Elise
    Ha, Jason
    Wynn, Ralph
    Zhao, Binsheng
    CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2016, 45 (05) : 297 - 303
  • [36] Impact of Tamoxifen on Amount of Fibroglandular Tissue, Background Parenchymal Enhancement, and Cysts on Breast Magnetic Resonance Imaging
    King, Valencia
    Kaplan, Jennifer
    Pike, Malcolm C.
    Liberman, Laura
    Dershaw, D. David
    Lee, Carol H.
    Brooks, Jennifer D.
    Morris, Elizabeth A.
    BREAST JOURNAL, 2012, 18 (06): : 527 - 534
  • [37] MR imaging of the liver: Effect of portal hypertension on hepatic parenchymal enhancement using a gadolinium chelate
    Soyer, P
    Dufresne, AC
    Somveille, E
    Scherrer, A
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (01): : 142 - 146
  • [38] Background Parenchymal Signal Enhancement Ratio at Preoperative MR Imaging: Association with Subsequent Local Recurrence in Patients with Ductal Carcinoma in Situ after Breast Conservation Surgery
    Kim, Sun-Ah
    Cho, Nariya
    Ryu, Eun Bi
    Seo, Mirinae
    Bae, Min Sun
    Chang, Jung Min
    Moon, Woo Kyung
    RADIOLOGY, 2014, 270 (03) : 699 - 707
  • [39] Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk
    Arasu, Vignesh A.
    Miglioretti, Diana L.
    Sprague, Brian L.
    Alsheik, Nila H.
    Buist, Diana S. M.
    Henderson, Louise M.
    Herschorn, Sally D.
    Lee, Janie M.
    Onega, Tracy
    Rauscher, Garth H.
    Wernli, Karen J.
    Lehman, Constance D.
    Kerlikowske, Karla
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (12) : 954 - +
  • [40] Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker
    Rella, Rossella
    Contegiacomo, Andrea
    Bufi, Enida
    Mercogliano, Sara
    Belli, Paolo
    Manfredi, Riccardo
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1119):